Literature DB >> 6473094

Binding of heparin and low molecular weight heparin fragments to human vascular endothelial cells in culture.

T Bârzu, P Molho, G Tobelem, M Petitou, J P Caen.   

Abstract

The interaction of standard heparin and some low molecular weight heparin fragments (CY 222, mw 1,500-8,000 daltons) with human vascular endothelium in culture was studied using both 125I and 3H labeled ligands. A specific and saturable binding was shown for both labeled standard heparins. Two populations of binding sites for 3H-standard heparin could be distinguished: one of high affinity (KD = 0.12 microM), and another of lower affinity (KD = 1.37 microM). Total binding capacity was in the order of 10(7) molecules per cell. The same high level of affinity was calculated for unlabeled compounds from competition experiments with 125I-standard heparin. No other glycosaminoglycans, except a highly sulfated heparan (fraction IIA) could compete for heparin binding sites. A specific binding was also shown for 125I-CY 222. The affinity of unlabeled CY 222 was approximately ten times lower than that of unfractionated heparin. However, CY 222 could compete for approximatively 30% of standard heparin binding. Binding was not completely reversible. Even in the presence of a large excess of unlabeled compounds, a fraction of 25% of radioactive heparins remained bound to the endothelium. This fraction was three times lower if incubation was carried out at +4 degrees C, suggesting a possible incorporation of heparin into the endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6473094

Source DB:  PubMed          Journal:  Nouv Rev Fr Hematol


  5 in total

1.  Investigations on plasma activity of low molecular weight heparin after intravenous and oral administrations.

Authors:  M Dryjski; D E Schneider; P Mojaverian; B S Kuo; T D Bjornsson
Journal:  Br J Clin Pharmacol       Date:  1989-08       Impact factor: 4.335

Review 2.  Initial anticoagulation in patients with pulmonary embolism: thrombolysis, unfractionated heparin, LMWH, fondaparinux, or DOACs?

Authors:  Jenneke Leentjens; Mike Peters; Anne C Esselink; Yvo Smulders; Cornelis Kramers
Journal:  Br J Clin Pharmacol       Date:  2017-07-09       Impact factor: 4.335

3.  Hydrogel surfaces to promote attachment and spreading of endothelial progenitor cells.

Authors:  Gulden Camci-Unal; Jason William Nichol; Hojae Bae; Halil Tekin; Joyce Bischoff; Ali Khademhosseini
Journal:  J Tissue Eng Regen Med       Date:  2012-01-06       Impact factor: 3.963

4.  Studies of interaction of a low-molecular-weight heparinoid (Org 10172) with cloxacillin and ticarcillin in healthy male volunteers.

Authors:  A de Boer; J C Stiekema; M Danhof; T G van Dinther; J K Boeijinga; A F Cohen; D D Breimer
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

5.  Endothelial binding sites for heparin. Specificity and role in heparin neutralization.

Authors:  T Bârzu; J L Van Rijn; M Petitou; P Molho; G Tobelem; J P Caen
Journal:  Biochem J       Date:  1986-09-15       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.